Avricore Health (AVCRF) Interest Coverage Ratio Growth (1y) (2010 - 2024)
Avricore Health (AVCRF) Interest Coverage Ratio Growth (1y) (2010 - 2024) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 14.65% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 3.80% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -91.18% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 120.45% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -7.61% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 97.40% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -28.45% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -11.26% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.67% |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.25% |
| Mar 31, 2023 | 336.62% |
| Dec 31, 2022 | -156,902.67% |
| Mar 31, 2022 | -1,666.70% |
| Dec 31, 2021 | -550.93% |
| Mar 31, 2021 | -8.64% |
| Jun 30, 2014 | 24.43% |
| Sep 30, 2013 | -445.01% |
| Jun 30, 2013 | 92.08% |
| Mar 31, 2013 | 15.88% |
| Dec 31, 2012 | -6.93% |
| Sep 30, 2012 | 85.84% |
| Jun 30, 2012 | -94,686.93% |
| Mar 31, 2012 | 56.38% |
| Dec 31, 2011 | 42.95% |
| Sep 30, 2011 | -109.92% |
| Jun 30, 2011 | 99.76% |
| Mar 31, 2011 | 46.96% |
| Dec 31, 2010 | -38.88% |
| Sep 30, 2010 | 87.00% |